Age and Incidence of Cochlear Implantation in the Pediatric Population With Congenital Bilateral Profound Hearing Loss.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
01 Aug 2023
Historique:
medline: 17 7 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

The current study characterizes age and incidence of cochlear implantation among qualifying children with congenital bilateral profound hearing loss in the U.S. Deidentified cochlear implantation data were acquired from prospectively collected patient registries from two cochlear implant (CI) manufacturers (Cochlear Americas and Advanced Bionics). Children <36 months old were assumed to have congenital bilateral profound sensorineural hearing loss. U.S. CI centers. Children <36 months old who received CIs. Cochlear implantation. Age at implantation and incidence. A total of 4,236 children <36 months old underwent cochlear implantation from 2015 to 2019. The median age at implantation was 16 months (interquartile range, 12-24 mo) and did not change significantly during the 5-year study period ( p = 0.09). Patients residing closer to CI centers ( p = 0.03) and treated at higher-volume centers ( p = 0.008) underwent implantation at a younger age. Bilateral simultaneous implantation increased from 38% to 53% of CI surgeries in 2015 and 2019, respectively. Children who received bilateral simultaneous CIs were younger compared with those receiving unilateral or bilateral sequential CIs (median, 14 versus 18 mo; p < 0.001). The incidence of cochlear implantation increased from 7,648 per 100,000 person-years in 2015 to 9,344 in 2019 ( p < 0.001). Although the incidence of pediatric CI recipients and the frequency of bilateral simultaneous implantation increased over the study period, age at implantation did not change significantly and far exceeded current Food and Drug Administration (9 mo) and American Academy of Otolaryngology and Head and Neck Surgery position statement (6-12 mo) guidelines.

Identifiants

pubmed: 37367698
doi: 10.1097/MAO.0000000000003932
pii: 00129492-990000000-00319
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e492-e496

Informations de copyright

Copyright © 2023, Otology & Neurotology, Inc.

Références

Waltzman SB, Shapiro WH. Cochlear implants in children. Trends Amplif 1999;4:143–62.
Sampaio AL, Araújo MF, Oliveira CA. New criteria of indication and selection of patients to cochlear implant. Int J Otolaryngol 2011;2011:573968.
Food and Drug Administration. Nucleus 24 Cochlear Implant System Pre-Market Approval (P970051/S172)2020; Accessed at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?start_search=1&PMANumber=P970051&SupplementNumber=S172 ; Accessed on March 3, 2023.
Karltorp E, Eklöf M, Östlund E, et al. Cochlear implants before 9 months of age led to more natural spoken language development without increased surgical risks. Acta Paediatr 2020;109:332–41.
Culbertson SR, Dillon MT, Richter ME, et al. Younger age at cochlear implant activation results in improved auditory skill development for children with congenital deafness. J Speech Lang Hear Res 2022;65:3539–47.
Dettman S, Choo D, Au A, et al. Speech perception and language outcomes for infants receiving cochlear implants before or after 9 months of age: use of category-based aggregation of data in an unselected pediatric cohort. J Speech Lang Hear Res 2021;64:1023–39.
Cosetti M, Roland JT Jr. Cochlear implantation in the very young child: issues unique to the under-1 population. Trends Amplif 2010;14:46–57.
Roland JT Jr., Cosetti M, Wang KH, et al. Cochlear implantation in the very young child: long-term safety and efficacy. Laryngoscope 2009;119:2205–10.
Chen Y, Li Y, Jia H, et al. Simultaneous bilateral cochlear implantation in very young children improves adaptability and social skills: a prospective cohort study. Ear Hear 2023;44:254–63.
Kim Y, Patel VA, Isildak H, et al. An analysis of safety and adverse events following cochlear implantation in children under 12 months of age. Otol Neurotol 2017;38:1426–32.
Carlson ML, Sladen DP, Haynes DS, et al. Evidence for the expansion of pediatric cochlear implant candidacy. Otol Neurotol 2015;36:43–50.
Carlson ML, Patel NS, Tombers NM, et al. Hearing preservation in pediatric cochlear implantation. Otol Neurotol 2017;38:e128–e33.
Chweya CM, Smith AJ, May MM, et al. Prevalence of surgical, anesthetic, and device-related complications among infants implanted before 9 and 12 months of age versus older children: evidence for the continued expansion of pediatric cochlear implant candidacy criteria. Otol Neurotol 2021;42:e666–e74.
Holman MA, Carlson ML, Driscoll CL, et al. Cochlear implantation in children 12 months of age and younger. Otol Neurotol 2013;34:251–8.
Kalejaiye A, Ansari G, Ortega G, et al. Low surgical complication rates in cochlear implantation for young children less than 1 year of age. Laryngoscope 2017;127:720–4.
American Academy of Otolaryngology–Head and Neck Surgery. Position Statement: Cochlear Implants. Available at: https://www.entnet.org/resource/position-statement-cochlear-implants/#:~:text=The%20American%20Academy%20of%20Otolaryngology,with%20appropriately%20fit%20hearing%20aids . Accessed March 3, 2023.
American Academy of Otolaryngology–Head and Neck Surgery. Position Statement: Pediatric Cochlear Implantation Candidacy. Available at: https://www.entnet.org/resource/position-statement-pediatric-cochlear-implantation-candidacy/ . Accessed March 3, 2023.
Varadarajan VV, Sydlowski SA, Li MM, et al. Evolving criteria for adult and pediatric cochlear implantation. Ear Nose Throat J 2021;100:31–7.
Arnoldner C, Lin VY. Expanded selection criteria in adult cochlear implantation. Cochlear Implants Int 2013;14(Suppl 4):S10–3.
Holder JT, Reynolds SM, Sunderhaus LW, et al. Current profile of adults presenting for preoperative cochlear implant evaluation. Trends Hear 2018;22:2331216518755288.
Carlson ML, O'Connell BP, Lohse CM, et al. Survey of the American Neurotology Society on cochlear implantation: part 2, surgical and device-related practice patterns. Otol Neurotol 2018;39:e20–e7.
Carlson ML, Sladen DP, Gurgel RK, et al. Survey of the American Neurotology Society on cochlear implantation: part 1, candidacy assessment and expanding indications. Otol Neurotol 2018;39:e12–e9.
Fujiwara RJT, Wong EC, Ishiyama A. Geographic variations in Medicare cochlear implantations in the United States. Otol Neurotol 2022;43:1022–6.
Findlen UM, Benedict J, Agrawal S. Clinical practice patterns of fitting advanced device features in children with cochlear implants. J Speech Lang Hear Res 2022;65:797–815.
Hoyle A. Head Aid Spells Growth, Market Share for Med-El. Available at: https://www.bizjournals.com/triangle/stories/2008/07/21/story1.html . Accessed August 23, 2022.
McRackan TR, Hand BN, Velozo CA, et al; Cochlear Implant Quality of Life Development Consortium. Cochlear implant quality of life (CIQOL): development of a profile instrument (CIQOL-35 profile) and a global measure (CIQOL-10 global). J Speech Lang Hear Res 2019;62:3554–63.
Dunn C, Miller SE, Schafer EC, et al. Benefits of a hearing registry: cochlear implant candidacy in quiet versus noise in 1,611 patients. Am J Audiol 2020;29:851–61.
Fitzgibbons EJ, Keszegi S, Driscoll C, et al. Childhood hearing loss detected beyond the newborn screen. Int J Audiol 2023;62:278–85.
U.S. Department of Agriculture Economic Research Service. Rural-urban continuum codes. Available at: https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx . Accessed February 2, 2023.
Hixon B, Chan S, Adkins M, et al. Timing and impact of hearing healthcare in adult cochlear implant recipients: a rural-urban comparison. Otol Neurotol 2016;37:1320–4.
Morton CC, Nance WE. Newborn hearing screening—a silent revolution. N Engl J Med 2006;354:2151–64.
Centers for Disease Control. Data and statistics about hearing loss in children. Available at: https://www.cdc.gov/ncbddd/hearingloss/data.html . Accessed February 10, 2023.
Korver AM, Smith RJ, Van Camp G, et al. Congenital hearing loss. Nat Rev Dis Primers 2017;3:16094.
United States Census Bureau. Population Statistics. Available at: https://www.census.gov/programs-surveys/popest/technical-documentation/research/evaluation-estimates/2020-evaluation-estimates/2010s-national-detail.html . Accessed September 11, 2022.
Gordon SA, Waltzman SB, Friedmann DR. Delayed cochlear implantation in congenitally deaf children-identifying barriers for targeted interventions. Int J Pediatr Otorhinolaryngol 2022;155:111086.
Fujiwara RJT, Ishiyama G, Ishiyama A. Association of socioeconomic characteristics with receipt of pediatric cochlear implantations in California. JAMA Netw Open 2022;5:e2143132.
DeVries J, Ren Y, Purdy J, et al. Exploring factors responsible for delay in pediatric cochlear implantation. Otol Neurotol 2021;42:e1478–e85.
Omar M, Qatanani A, Kaleem SZ, et al. Sociodemographic disparities in pediatric cochlearimplantation access and use: a systematic review. Laryngoscope 2022;132:670–86.
Park LR, Preston E, Eskridge H, et al. Sound opportunities: factors that impact referral for pediatric cochlearimplant evaluation. Laryngoscope 2021;131:E2904–E10.
Nassiri AM, Marinelli JP, Sorkin DL, et al. Barriers to adult cochlearimplant care in the United States: an analysis of health care delivery. Semin Hear 2021;42:311–20.
Centers for Disease Control and Prevention. Early hearing detection and intervention (EDHI): hearing screening and follow-up survey (HSFS). Available at: https://www.cdc.gov/ncbddd/hearingloss/ehdi-data2019.html . Accessed February 24, 2023.
Mathew R, Bajo FR, Hatton N, et al. Assessment of the cochlear implant pathway for newborn hearing screening referrals. Cochlear Implants Int 2021;22:345–52.

Auteurs

Ashley M Nassiri (AM)

Department of Otolaryngology-Head and Neck Surgery, University of Colorado Anschutz School of Medicine, Aurora, CO.

John P Marinelli (JP)

Departments of Otolaryngology-Head and Neck Surgery.

Christine M Lohse (CM)

Quantitative Health Sciences, Mayo Clinic, Rochester, MN.

Matthew L Carlson (ML)

Departments of Otolaryngology-Head and Neck Surgery.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH